.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Federal Trade Commission
Citi
Deloitte
Baxter
Novartis
Moodys
Julphar
Boehringer Ingelheim
Chinese Patent Office

Generated: December 15, 2017

DrugPatentWatch Database Preview

SELEGILINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Selegiline Hydrochloride patents expire, and what generic alternatives are available?

Selegiline Hydrochloride is a drug marketed by Apotex, Dava Pharms Inc, Lannett Holdings Inc, Apotex Inc, Boscogen, Chartwell Molecules, G And W Labs Inc, Mylan, Siegfried, and Somerset. and is included in thirteen NDAs.

The generic ingredient in SELEGILINE HYDROCHLORIDE is selegiline hydrochloride. There are seventeen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the selegiline hydrochloride profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
ApotexSELEGILINE HYDROCHLORIDEselegiline hydrochlorideCAPSULE;ORAL075321-001Dec 4, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
Chartwell MoleculesSELEGILINE HYDROCHLORIDEselegiline hydrochlorideTABLET;ORAL074641-001Aug 2, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Apotex IncSELEGILINE HYDROCHLORIDEselegiline hydrochlorideTABLET;ORAL074871-001Jun 6, 1997ABRXNoYes► Subscribe► Subscribe► Subscribe
SiegfriedSELEGILINE HYDROCHLORIDEselegiline hydrochlorideTABLET;ORAL074672-001Apr 1, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
G And W Labs IncSELEGILINE HYDROCHLORIDEselegiline hydrochlorideTABLET;ORAL074537-001Aug 2, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Dava Pharms IncSELEGILINE HYDROCHLORIDEselegiline hydrochlorideCAPSULE;ORAL075352-001Nov 30, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
Lannett Holdings IncSELEGILINE HYDROCHLORIDEselegiline hydrochlorideCAPSULE;ORAL075145-001Sep 15, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Chartwell MoleculesSELEGILINE HYDROCHLORIDEselegiline hydrochlorideTABLET;ORAL074565-001Aug 2, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
BoscogenSELEGILINE HYDROCHLORIDEselegiline hydrochlorideTABLET;ORAL074912-001Apr 30, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
G And W Labs IncSELEGILINE HYDROCHLORIDEselegiline hydrochlorideTABLET;ORAL074756-001Nov 25, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Teva
Argus Health
Novartis
Johnson and Johnson
Mallinckrodt
Fish and Richardson
Merck
US Department of Justice
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot